|
General Information
|
|
|
Product
|
MYLK2 Peptide
|
|
Description
|
Antigenic Blocking Peptide Myosin light chain kinase 2 Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
|
|
|
Peptide Description
|
Synthetic peptide taken within aino acid region 200-250 on human Myosin light chain kinase 2 protein.
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9H1R3
|
|
Overview
|
Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain.
|
|
Molecular Function
|
ATP binding
calmodulin binding
calmodulin-dependent protein kinase activity
myosin light chain kinase activity
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Heart and skeletal muscles. Increased expression in the apical tissue compared to the interventricular septal tissue.
|
|
Structure
|
Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.
|
|
Alternative Nomenclature
|
KMLC antibody
MLCK antibody
MLCK2 antibody
MYLK 2 antibody
Myosin light chain kinase 2 antibody
MYOSIN LIGHT POLYPEPTIDE KINASE antibody
Myosin light polypeptide kinase, skeletal/cardiac antibody
skeletal/cardiac muscle antibody
skMLCK antibody
|
|
|
|
MYLK2 Antibody
MYLK2 Antibody BIOTIN
MYLK2 Antibody FITC
MYLK2 Positive Control
